Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure
- 1 May 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (16), 1121-1126
- https://doi.org/10.1016/0002-9149(90)90325-u
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonanceThe American Journal of Cardiology, 1988
- Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.Circulation, 1987
- Detection of skeletal muscle hypoperfusion during exercise using phosphorus-31 nuclear magnetic resonance spectroscopyJournal of the American College of Cardiology, 1986
- Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.Circulation, 1984
- Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamineThe American Journal of Cardiology, 1984
- Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failureThe American Journal of Cardiology, 1983
- Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.Circulation, 1982
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.Circulation, 1977
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamineAmerican Heart Journal, 1975